Oral Session 1-15B Aplastic Anemia: Clinical

[OS1-15B-6] A subpopulation analysis of phase 2/3 clinical trial with romiplostim in second-line aplastic anemia

Koji Nagafuji¹, Jun Ho Jang², Jong Wook Lee³, Yoshiaki Tomiyama⁴, Koji Miyazaki⁵, Kensuke Usuki⁶, Nobuhiko Uoshima⁷, Tomoaki Fujisaki⁸, Hiroshi Kosugi⁹, Itaru Matsumura¹⁰, Ko Sasaki¹¹, Masahiro Kizaki¹², Masashi Sawa¹³, Michihiro Hidaka¹⁴, Naoki Kobayashi¹⁵, Satoshi Ichikawa¹⁶, Yuji Yonemura¹⁷, Kouki Enokitani¹⁸, Akira Matsuda¹⁹, Keiya Ozawa²⁰, Kinuko Mitani¹¹, Shinji Nakao²¹ (1.Kurume University Hospital, Fukuoka, Japan, 2.Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea, 3.Seoul St. Mary's Hospital, Seoul, Republic of Korea, 4.Osaka University Hospital, Osaka, Japan, 5.Kitasato University Hospital, Kanagawa, Japan, 6.NTT Medical Center Tokyo, Tokyo, Japan, 7.Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 8.Matsuyama Red Cross Hospital, Ehime, Japan, 9.Ogaki Municipal Hospital, Gifu, Japan, 10.Kindai University Hospital, Osaka, Japan, 11.Dokkyo Medical University, Tochigi, Japan, 12.Saitama Medical Center, Saitama, Japan, 13.Anjo Kosei Hospital, Aichi, Japan, 14.National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan, 15.Sapporo Hokuyu Hospital, Hokkaido, Japan, 16.Tohoku University Hospital, Miyagi, Japan, 17.Kumamoto University Hospital, Kumamoto, Japan, 18.Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan, 19.International Medical Center, Saitama Medical University, Saitama, Japan, 20.Jichi Medical University, Tochigi, Japan, 21.Kanazawa University, Ishikawa, Japan)